FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Authority Hl7

17,829 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 2200 - 2400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2107Methemoglobinemia (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2108Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2109Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative])active2023-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2110Anencephaly (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2111Anencephaly (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2112Fetal Anencephaly (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2113Fetal Anencephaly (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2114Cleft Lip Alone (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2115Cleft Lip Alone (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2116Fetal Cleft Lip (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2117Cleft Palate Alone (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2118Cleft Palate Alone (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2119Cleft Lip with Cleft Palate (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2120Cleft Lip with Cleft Palate (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2121Fetal Spina Bifida (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2122Spina Bifida (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2123Spina Bifida (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2124Down Syndrome (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2125Down Syndrome (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2126Fetal Down Syndrome (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2127Fetal Down Syndrome (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2128Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2129Bacteremia (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2130Bacteremia (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2131Gastroschisis (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2132Gastroschisis (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2133Fatal Familial Insomnia (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2134Fatal Familial Insomnia (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2135Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2136Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2137Prion Disease (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2138Prion Disease (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2139Prion Disease (Tests for Abnormal PRNP Gene Variant)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2140Phenylketonuria (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2141Phenylketonuria (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2145Tuberculosis [Suspected] (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2146Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2147Limb Reduction (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2148Limb Reduction (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2149NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid)active2023-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2150Congenital Hearing Loss (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2151Congenital Hearing Loss (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2152Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid)active2023-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2153Primary Congenital Hypothyroidism (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2154Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2155Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2156Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2157Mpox (Combination Tests that include mpox virus Nucleic Acid)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2158Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2159Mpox (Test Panels for mpox virus Nucleic Acid)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.216Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody])active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2160Orthopox (Test Panels for orthopoxvirus Nucleic Acid)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2161COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid)active2023-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2163Dengue Virus Infection [Suspected] (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2164Mumps [Suspected] (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2165Pertussis [Suspected] (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2166Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2167Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2168Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2169Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2170Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2171Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2172Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2173Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2174Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2175Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2176Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2177Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2178Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2179Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.218Listeriosis (Disorders) (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2180Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2181Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2183Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2187Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2188Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2189Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2190Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2192Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2193Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2196Lung Tissue (Specimen Type) (SNOMED)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2197Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results)active2023-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2198Anaplasmosis (Disorders) (ICD10CM)active2023-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2199NU_Organisms (Tests in Specimen from Wound by Culture and Identification Methodactive2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2200Organisms (Tests by Animal Inoculation Method)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2201Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM)active2023-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2202Abnormal Lung Sounds (SNOMED)active2023-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2203Abnormal Lung Sounds (ICD10CM)active2023-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2204Anemia [Unspecified Cause] (SNOMED)active2023-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2205Anemia [Unspecified Cause] (ICD10CM)active2023-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2206Creatinine (Tests in Serum by Any Method)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2207Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2208Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood)active2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2209Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results)active2023-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2210Histopathology or Cytopathology Tests by Microscopic Observationactive2023-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2211Ehrlichiosis (Tests for Ehrlichia species IgG Antibody)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2212Invasive Cronobacter Infection (Organism or Substance in Lab Results)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2213Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2214Necrotizing Enterocolitis (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2215Necrotizing Enterocolitis (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2216Abscess [Brain] (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2217Abscess [Brain] (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2218Urinary Tract Infection (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2219Urinary Tract Infection (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2220Amniotic Fluid (Specimen Type) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2221Congenital Cytomegalovirus (Organism or Substance in Lab Results)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2222Organisms (Tests in Amniotic Fluid by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2223Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2224Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2225Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2226Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2227Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2228Congenital Cytomegalovirus (Tests for CMV Antigen)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2229Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2230Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2231Congenital Cytomegalovirus Infection (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2232Congenital Cytomegalovirus Infection (Disorders) (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2233Cytomegalovirus Disease (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2234Cytomegalovirus Disease (Disorders) (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2235Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2236Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2237Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2238Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2239Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2240Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2241Stillbirth (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2242Stillbirth (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2243Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2244Candida species (Tests by Culture and Identification Method)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2245Organisms (Tests in Extrapulmonary Specimen by Culture and Identification)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2246Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2247Extrapulmonary [NTM] (Specimen Type) (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2248Plasmodium species (Tests by Microscopic Observation)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2249Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2250Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2251Organisms (Tests in Sputum Specimen by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2252Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2253Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] )active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2254Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2255Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2256CP_CRE (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2257Organisms (Tests in Stool by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2258Loss of Consciousness (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2259Neonatal Abstinence Syndrome (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2260Neonatal Abstinence Syndrome (Disorders) (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2261High Pitched Cry (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2262Inability to Console (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2263Inability to Console (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2264Hypertonia (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2265Hypertonia (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2266Tremors (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2267Tremors (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2268Myoclonus (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2269Myoclonus (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2270Poor Sleep (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2271Poor Sleep (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2272Alterations in Feeding (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2273Alterations in Feeding (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2274Excoriation (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2275Excoriation (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2276Sneezing (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2277Sneezing (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2278Nasal Congestion (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2279Nasal Congestion (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2280Yawning (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2281Cutaneous Mottling (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2282Sweating (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2283Sweating (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2284Feeding Intolerance (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2285Feeding Intolerance (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2286Respiratory Distress or Nasal Flaring (SNOMED)active2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2287Respiratory Distress or Nasal Flaring (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2288In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2289In Utero Substance Exposure (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2290In Utero Substance Exposure (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2291Childbirth (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2292Childbirth (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2293Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2294NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2295Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2296NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2297Exposure or suspected exposure to harmful algae or algae toxins (SNOMED)active2024-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2298Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM)active2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2299Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method)active2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2300Babesia species (Tests by Microscopic Observation)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2301Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2302Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2305Gram_negative Diplococcus (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2306Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method)active2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2307D_Transposition of the Great Arteries (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2308L_Transposition of the Great Arteries (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2309Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2310Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM)active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2311Interrupted Aortic Arch (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2312Interrupted Aortic Arch (Disorders) (ICD10CM)active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2313Coarctation of the Aorta (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2314Coarctation of the Aorta (Disorders) (ICD10CM)active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2315Ebstein Anomaly (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2316Ebstein Anomaly (Disorders) (ICD10CM)active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2317Pulmonary valve atresia (Disorders) (SNOMED)active2024-06ussct